| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $1.10M | $1.08M | $1.17M | $1.23M | $1.17M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | -$1.10M | -$1.08M | -$1.17M | -$1.23M | -$1.17M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | $2.00K |
| Net Income | -$1.02M | -$920.00K | -$1.01M | -$1.21M | -$1.12M |
| EPS (basic) | -0.0500 | -0.0400 | -0.0500 | -0.0600 | -0.0600 |
| EPS (diluted) | -0.0500 | -0.0400 | -0.0500 | -0.0600 | -0.0600 |
| Shares (diluted) | $20.62M | $20.62M | $20.62M | $20.50M | $20.29M |